The high percentage of clinically aggressive tumours that we observed showed promoter methylation, but the absence of promoter mutations (60%, 12/20) denotes the limited prognostic predictive value of testing only TERT promoter mutations, which is in consonance with previous studies.17, 46. Here, TERT is linked to neoplasm.